Cytokinetics, Incorporated · NASDAQ:CYTK
FMR LLC's stake in Cytokinetics, Incorporated fell to 3.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
FMR LLC's stake in Cytokinetics, Incorporated fell to 3.90%, 5,248,580 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 3.90%
- Shares
- 5,248,580
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 3.90% | 5,248,580 |
| Abigail P. Johnson | 3.90% | 5,248,580 |
Source
Related
- Cytokinetics, Incorporated
- FMR LLC
- Cytokinetics, Incorporated shareholders
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2025
- Schedule 13G/A · FMR LLC · Feb 12, 2025
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026